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The bacteriocins are an intriguing potpourri of bactericidal antibiotics, having a 
wide range of different genetic determinants, physicochemical properties, and killing 
mechanisms (1).  Bacteriocinogeny seems  an almost universal property  of  bacteria 
and various strains of most species  have now been shown to produce bacteriocins. 
Although there have been several reports of bacteriocin-like inhibition produced by 
Group A streptococci on solid media (2-4), progress in this field has been hampered 
by the inability to demonstrate the active bacteriocin in broth cultures. 
A  streptococcal bacteriocin was recently obtained in cell-free form following 
"freeze-thaw"  extraction of  the  liquor from  cultures grown on  Oxoid Todd- 
Hewitt  agar  (4,  5).  The  producer  organism was  a  Group  A  beta-hemolytic 
streptococcus  (strain FF-22)  and  the  bacteriocin was  correspondingly named 
streptocin A. The present communication is concerned with  the isolation and 
purification of streptocin A  from broth  cultures of  this same producer strain 
and an investigation of the mode of action of the bacteriocin against a  suscep- 
tible  Group A  streptococcus.  Several  properties  of  the  bacteriocin are  com- 
pared with those of a bacteriocin produced by a strain of phage type 71 Staphy- 
lococcus  aureus. 
Materials and Methods 
Bacterial Strains.--Group  A streptococcus strain FF-22 (5) and S. aureus strain C55  (6) 
were the  organisms used for  the  production  of the  streptococcal and staphylococcal bac- 
teriocins. Various other strains were utilized as indicators in studies of the specificity of the 
range of bactericidal activity of these bacteriocins. Group A streptococcus strain PF 1643 (6) 
is an indicator sensitive to both streptocin A and staphylococcin. S. aureus strain 502A (6) 
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is susceptible to staphylococcin, but not to streptocin A. Escherichia  coli B  is an organism 
resistant to both bacteriocins. When in regular use the bacteria were subcultured weekly on 
Todd-Hewitt agar and stored at 4°C.  Stock cultures were  maintained at  -70°C  or  as  ly- 
ophilized preparations. 
Media and Chemicals.--Liquid media tested as substrates for the production of bacteriocin 
were  Todd-Hewitt  broth  (Oxo  Ltd.,  London),  Trypticase  soy broth  (Baltimore Biological 
Laboratories,  Baltimore,  Md.),  and  also  tryptic soy  broth,  brain-heart infusion,  tryptose 
phosphate broth, and Todd-Hewitt  broth from Difco Laboratories,  Detroit,  Mich.  Unless 
stated  otherwise,  Dffco  rather than  Oxoid  Todd-Hewitt  broth  was  used  in  the  present 
studies. A dialysate of tryptic soy broth was prepared as previously described (7). 
Blue dextran 2000 and Sephadex G-25 and G-100 were from Pharmacia Fine Chemicals, 
Inc., Piscataway, N. J. Reference proteins used to calibrate the Sephadex G-100 column were 
obtained from Sigma Chemical Co., St. Louis, Mo. (type III cytochrome c; glucagon) and from 
Miles Laboratories, Inc., Kankakee,  IlL  (horse skeletal muscle myoglobin). Purified casein 
was from Difco Laboratories. [Methyl3H]thymidine,  [53H]uridine, L-[3H]alanine,  and D-[14C]- 
glucose were purchased from New England Nuclear, Boston, Mass. 
Purification  of Bacteriocins.--In a typical procedure for the production and purification of 
streptocin A, the cells from a 500-ml overnight tryptic soy broth culture of the producer strain 
were collected by centrifugation, resuspended in 100 ml of fresh medium, and then reinoculated 
into 10 liters of sterile trypfic soy broth. This culture was incubated at 35°C without agitation 
for 24-36 h, then the supernatant fluid was harvested by filtration through Filter Cel (Hyflo 
Filter Cel,  Johns-Manville, New York). Mter boiling the liquor for 30 rain and then cooling 
to room temperature, the pH was adjusted to 6.5 with NaOH, and solid ammonium sulfate 
was added slowly to achieve 80% saturation. Stirring was continued for 6 h  at 4°C  before 
collecting the precipitate on Filter Cel and then eluting it into a minimum volume of distilled 
water. This preparation was desalted and fractionated by gel filtration on Sephadex G-25 to 
give preparations of "crude streptocin A." Further purification of the bacteriocin was by ion 
exchange chromatography on carboxymethyl cellulose  (5).  Subsequently, dialysis and con- 
centration of the material in a Diaflo ultrafilter by use of a UM-2 membrane (Amicon Corp., 
Lexington, Mass.) gave the final product referred to here as "purified streptocin A." 
Crude staphylococcin was obtained by the method described elsewhere (7). Sterilization of 
the staphylococcin or streptocin A preparations was achieved either by boiling for 30 rain or 
by filtration through a  0.45-#m pore size filter  (Millipore Corp.,  Bedford, Mass.).  Storage 
was at 4°C. 
Demonstration  of Inhibitory  Activity.--The  titer of inhibitory activity of both the strepto- 
coccal and staphylococcal bacteriocins was determined by use of a standard surface-spotting 
dilution test on lawn cultures of the susceptible indicator streptococcus (strain PF 1643)  (5). 
The highest twofold dilution of the test preparation to give definite inhibition of the indicator 
lawn was defined as containing 1 arbitrary unit (A.U.) I of bacteriocin per milliliter. Specific 
activities were expressed in terms of A.U.  per milligram protein, after quantitation of the 
amount of protein in the samples by the method of Lowry et al. (8). 
The bactericidal activity of the bacteriocins was determined by measurement of the de- 
crease with time in the number of colony-forming units (CFU) of a suspension of the sensitive 
indicator streptococcus after mixing the cells with a  bacteriocin preparation. Twice-washed 
ceils from an exponential Todd-Hewitt broth culture of Group A streptococcus strain PF 1643 
were resuspended in 0.067  M  phosphate buffer (pH 6.5)  to the original culture volume. Por- 
tions of the bacteriocin or of phosphate buffer (control) were then mixed with an equal volume 
of the washed cell suspension and incubation was continued at the appropriate temperature. 
OD readings of the control and test cell suspensions were made at 600 nm in a Coleman Junior 
1  Abbreviations  used in this paper; A.U., arbitrary units of bacteriocin; CFU,  colony-form- 
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Spectrophotometer  (Coleman Instruments  Div.; Perkin  Elmer Corp.,  !V[aywood, Ill.)  using 
blanks of phosphate buffer and of a 1:1 mixture of bacteriocin:buffer, respectively. Survivors 
were determined at intervals by plating suitable 10-fold dilutions (in cold Todd-Hewitt broth) 
of the test and control mixtures on Todd-Hewitt agar and incubating at 35°C for 18 h. Viable 
counts were expressed  as the total number of CFU per milliliter. 
Streptococcal Proteinase  Assay.--The assay utilized was essentially as described by Liu et al. 
(9) and is based upon the digestion of casein by the activated proteinase. One unit of proteinase 
activity corresponded to the solubilization of 0.1 absorbancy unit at 280 nm in a 30-rain assay. 
Molecular Weight  Estimation.--A 2.5 X  90-cm column of Sephadex G-100 was equilibrated 
with sodium phosphate  buffer  (0.02 M; pH  7.0)  at 4°C. All samples were applied in 20% 
(wt/vol) sucrose.  Blue dextran (0.2% wt/vol) was  used  to estimate  the  void  volume  (Vo) 
and myoglobin, cytochrome c, and glucagon were the reference proteins used to construct the 
standard curve. Eluted fractions were collected and assayed for absorbance at 280 nm and for 
streptocin A activity. The elution volume (V~)  of the standards and of the bacteriocin were 
determined, and from the standard  curve of VE/Vo against the logarithm of the molecular 
weight, the molecular weight of streptoein A could be estimated. 
Incorporation of Radioactive Materials.--Protein,  DNA and RNA synthesis, and the forma- 
tion of acid-insoluble glucose products were determined by measurement of the incorporation 
of the  radioactive precursors  [3H]alanine,  [~H]thymidine,  [3H]uridine,and  [14C]glucose into 
tr;chloroacetic acid (TCA)-precipltable material. An exponentially growing culture of the test 
strain in Todd-Hewitt broth was added in 3.5-ml volumes to paired tubes, each containing 
0.1  ml of the labeled precursor (final activity 3.0 #Ci/ml). At 5 and 20 min, 0.3-ml samples 
were removed and added to 3.0 ml of cold 5% TCA. At 30 min, each pair of tubes received 
3.0 ml of either the bacteriocin or 0.067 M phosphate buffer (pH 6.5).  Samples of 0.6 ml were 
taken at intervals into cold TCA. Each time, before withdrawing a sample, the cultures were 
mixed briefly.  The  material  precipitated  by TCA after  30  min was  collected on 0.45-~m 
Millipore filters, washed twice with 5-ml aliquots of ice-cold  5% TCA, and  then once with 
2 ml of 95% ethanol. Finally, the filters were dried before counting. 
Incorporation of [14C]glucose into glycogen-like material was measured essentially accord- 
ing to the method of Abraham and Hassid  (10). Samples were withdrawn from the test and 
control mixtures, placed in 2.0 ml of KOH and then boiled for 20 rain.  Mter adding one drop 
of I0 M LiCI and cooling to 4°C, glycogen-like polymer material was precipitated by addition 
of 4.0 ml of cold 95% ethanol. The precipitate was collected by filtration, washed twice with 
5-ml volumes of a  1:2 mixture of cold buffer:ethanol, dried,  and counted. Total uptake of 
labeled glucose was determined by chilling samples  of the test and  control preparations  in 
3.0 ml of cold phosphate  buffer  (pH  7.1),  collecting the cells  on membrane filters,  washing 
twice in 5-ml aliquots of cold buffer,  drying and  then counting. All samples in these experi- 
ments were counted in a Beckman (Beckman Instruments,  Inc., Electron Instruments  Div, 
Shilier Park, Ill.) LS-150 liquid scintillation counter using a toluene-based fluor. 
RESULTS 
Recovery of Streptocin A from Broth Cultures.--Attempts were made to recover 
active bacteriocin from the supernatant  fluid of cultures of Group A  streptococ- 
cus  strain  FF-22  grown  in  various liquid media,  under  different physical  con- 
ditions.  Parameters  varied  were temperature  (22 °, 30  °, 35 °, 39°C),  time  (4,  8, 
12, 24, 36, 48, 60, 72 h), and the degree of mixing (gently shaken or still cultures). 
Active bacteriocin  could be  recovered from cultures  in  tryptic  soy broth,  a 
dialysate  of  tryptic  soy  broth  and  Difco  Todd-Hewitt  broth,  but  not  from 
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brain-heart infusion. The yield of streptocin A from tryptic soy broth cultures 
(inhibitory  titer of up to 4 A.U./ml)  was considerably greater than  that  ob- 
tained  from  cultures  in  tryptic  soy  broth-dialysate  or  Difco  Todd-Hewitt 
broth  (titer not greater than  1 A.U./ml). Active bacteriocin could not be re- 
covered from shaken cultures. Table I  shows the inhibitory titer of streptocin 
A  in  samples withdrawn  at  intervals from tryptic soy broth  cultures  of the 
producer strain incubated at various temperatures. Greatest recovery was from 
cultures incubated at 35°C for 24-48 h. No activity could be detected until at 
least 12 h  incubation and the yield decreased beyond 48 h. There did not ap- 
pear to be any production of active streptocin A during growth at 39°C. 
Factors Influencing the Yield of Streptocin  A.--Significant fluctuations in the 
yield of streptocin A have sometimes been observed to occur in different trypfic 
TABLE I 
Titer* ~Streptocin A in TrypticSoyBroth C~tur~ 
Temperature (°C) of incubation 
Incubation period 
22  30  35  39 
h 
4  0  0  0  0 
8  0  0  0  0 
12  0  1  2  0 
24  1  1  2  0 
36  2  2  4  0 
48  2  2  4  0 
60  2  2  2  0 
72  2  1  2  0 
* Measured in arbitrary units of streptocin A per milliliter. 
soy broth  cultures,  apparently  incubated  under  identical  conditions.  These 
findings emphasize the possible role of ill-defined factors in the in vitro produc- 
tion of the bacteriocin. The failure to recover active streptocin A from producer 
strain cultures in certain types of liquid media may be interpreted as being due 
either  to  specific deficiencies  in  the  growth  medium  or  to  the  concomitant 
synthesis of streptocin  A-inactivating  substances  (such  as  streptococcal pro- 
teinase) in these media. 
Proteinase  activity  was  measured  in  culture  supernatants  obtained  from 
samples taken during the growth (at 35°C) of the streptocin A producer strain 
in different liquid media (Table II). Media failing to support the production of 
active bacteriocin, such as Oxoid Todd-Hewitt broth and brain-heart infusion, 
had the highest levels of proteinase activity in 24- or 48-h cultures. Addition of 
2 %  (wt/vol)  neopeptone to Oxoid Todd-Hewitt broth  suppressed proteinase 
production and also facilitated the recovery of detectable bacteriocin. 
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streptococcal proteinase  was accrued from the observation  that,  although the 
production of active bacteriocin appeared significantly suppressed by repeated 
(10-fold)  subculture  of the producer strain  on Oxoid Todd-Hewitt  agar,  pro- 
duction could be restored to former levels by passing the strain through mice, a 
procedure  previously  shown  to  result  in  decreased  proteinase  formation  by 
Group A  streptococci (11). 
Purification  of Streptocin  A.--Since  crude tryptic soy broth producer strain 
cultures  rarely  contained  greater  than  4  A.U.  of streptocin  A  per  milliliter, 
purification of the bacteriocin involved the processing of large volumes of broth 
culture.  Boiling  the  crude  filtrate  for 30 min  achieved  the  dual  function  of 
sterilizing  the  fluid  and  of  inactivating  heat-labile  streptococcal  enzymes. 
Fractionation  of  crude  filtrates  with  ammonium  sulfate  indicated  that  the 
greatest  specific activity of bacteriocin  was obtained  in  the range  of 60-80% 
saturation.  However,  since  significant  quantities  were  also  recovered  in  the 
range 30-60%, routine processing involved the collection of all of the material 
precipitated  by addition  of ammonium sulfate  to 80%  saturation.  Results  of 
the purification of streptocin A  are summarized in Table III. Although a  139- 
TABLE II 
Rdationshlp  between Proteinase  and Streptocin  A  Activity in Broth  Cultures 
Growth medium 
Units of proteinase activity*  StreptocinAtiter~ 
24 h  48 h  24 h  48 h 
Tryptic soy broth  2.1  3.2  2  4 
Todd-Hewitt  broth (Difco)  2.9  3.5  1  1 
Todd-Hewitt  broth (Oxoid)  7.6  10.4  0  0 
Todd-Hewitt  broth (Oxoid)  3.4  4.6  0  1 
+  2% neopeptone 
Brain-heart  infusion  6.7  7.6  0  0 
* Per milliliter of culture supernatant. 
~: In arbitrary units per milliliter of culture supernatant. 
TABLE III 
Purification  of Streptocln  A 
Bacteriocin/  Protein  Specific  Times  Volume  ml  activity Recovery purified 
ml  A .U.  mg  A .U./mg  % 
Crude filtrate  10,000  20,000  91,000  0.22  100  1 
Ammonium sulfate  200  6,400  16,600  0.39  32  1.8 
precipitate  0-80% 
Sephadex  G-25 chromatog-  1,010  4,040  8,680  0.47  20  2.1 
raphy (crude streptocin A) 
Carboxymethyl cellulose  126  2,016  76  26.53  10  120 
chromatography 
Diaflo concentrate  (purified  22  1,408  46  30.61  7  139 
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fold purification was achieved, there appeared to be considerable loss of total 
activity during purification, with only 7 %  of the original amount recovered. 
Physical  Properties  of Streptocin  A.--Investigations  of  the  elution  char- 
acteristics of streptocin A on a  calibrated column of Sephadex G-100  (Fig. 1) 
gave an apparent molecular weight of approximately 8,000.  The bacteriocin 
was eluted from the column as a  single peak of activity, indicating that the 
streptocin A  in  the preparation  was probably homogeneous with respect  to 
molecular size. 
Other  properties  investigated were  the  sensitivity to  temperature  and  to 
change in pH and the susceptibility of the bacteriocin to the action of proteolytic 
enzymes. Streptocin A was stable to heating, with no detectable loss of activity 
on boiling for 60 min. Although the bacteriocin was stable to pH adjustment 
2 
",~.~rlochromo C 
--  ~  ~reptocin  ,4 
<_) 
o 
2,0  2,5  3,0  5,5  4,0  4,5 
VE/Vo 
FIo. 1.  Estimation of the molecular weight of streptocin A, using a calibrated column of 
Sephadex G-100 as outlined in the text. The migration of marker proteins and streptocin A is 
expressed  relative to the migration of Blue dextran  (VE/Vo). A molecular weight of 8,000 
can be extrapolated from the relative migration of streptocin A. 
within the range of 2-7, it was inactivated by alkali, with no detectable activity 
after adjustment to a pH of 11  or higher. Treatment with 1 mg/ml of either 
trypsin or pronase inactivated the bacteriocin during incubation for 60  rain 
at 37°C.  In  all of these properties  the bacteriocin purified from tryptic soy 
broth cultures appeared similar to the product obtained in previous investiga- 
tions from Oxoid Todd-Hewitt agar cultures of the producer strain (5). 
Bactericidal Action of Streptocin A.--Preliminary  experiments demonstrated 
that the lethal effect of streptocin A, as demonstrated by loss of colony-forming 
ability, was more pronounced against cells in the exponential phase of growth 
than those in stationary phase. The lethal action of streptocin A at different 
concentrations was investigated to determine an appropriate level of activity 
for use in subsequent studies. It was found that preparations of crude streptocin 
A of titer 16 were lethal for over 99 % of the CFU of exponential Todd-Hewitt 
broth cultures of Group A  streptococcus strain PF  1643 in 4  h  at 37°C. All 
streptocin A preparations utilized in subsequently described experiments had a 
titer of 16 A.U./ml. 1174  GROUP  A  STREPTOCOCCAL  BACTERIOCIN 
Investigation of the effect of the bacteriocin on the optical density of sus- 
pensions of the susceptible indicator strain at 37°C indicated that, in spite of a 
considerable decrease in the number of CFU, there was no apparent change in 
the optical density of the preparations and hence, that the lethal effect was not 
accompanied by cell lysis (Fig. 2). It can also be seen that the temperature of 
incubation had a marked effect on the bactericidal action, with less killing at 
lower temperatures. 
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FIG. 2.  The effect of crude streptocin A  (O---O) or 0.067 M phosphate buffer (0---0) on 
the optical density (OD 600 am) at 37°C and viability (CFU/milliliters) of a  suspension of 
cells of Group A  streptococcus strain PF  1643.  The bactericidal effect of streptocln A  was 
determined at 37  °,  25  °, and 4°C. 
Streptocin A  had  no  significant  bactericidal  effect against  cultures  of S. 
aureus strains  C  55 and 502A or against E. coli B. The bacteriocin producer 
(strain  FF-22)  showed some sensitivity to streptocin A  preparations of titer 
greater than 16, indicating incomplete immunity to the homologous bacteriocin. 
Effect of Streptocin A  on Macromolecule  Synthesis.--Since other bacteriocins 
have  been  shown  to inactivate particular  biochemical  targets  in  susceptible 
bacteria, efforts were made to determine the effect of streptocin A on various 
macromolecular syntheses in a  sensitive indicator streptococcus. 
Treatment of cells of Group A  streptococcus strain PF  1643  with crude or 
purified preparations  of streptocin A  resulted in  rapid  shutdown of the bio- 
synthesis of protein and DNA,  as demonstrated by the inhibition of the in- TAGG~  DAJANI~  WANNAMAKER  7  AND  GRAY  1175 
corporation of the appropriate radioactive precursors into acid-insoluble mate- 
rial. As can be seen in Figs. 3 and 4, both protein and DNA synthesis appeared 
to be stopped shortly after the addition of streptocin A while continuing steadily 
in control preparations. Streptocin A was inactivated by adjustment to pH 11 
for 24  h  and  then readjustment  to pH  6.5  (4).  This preparation  was  non- 
inhibitory when assayed on a lawn culture of strain PF 1643 and moreover, it 
was shown to have only a minimal effect on the uptake of acid-insoluble [3HI 
thymidine by this strain (Fig. 5). 
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FI6. 3. The uptake of L-[3H]alanine by Group A streptococcus strain PF 1643 and the 
effect of addition ($) of purified streptocin A (O--O) or 0.067 M phosphate buffer (Q---O) 
on incorporation. 
Investigation  of  the  effect of  the  bacteriocin on  RNA  synthesis  (Fig.  6) 
showed a significant decrease in the amount of acid-precipitable labeled RNA 
after  treatment  of  the  sensitive  indicator  with  streptocin  A.  This  finding 
indicated RNA breakdown in the treated cells.  In other experiments similar 
RNA degradation was detected after treatment of the bacteria with streptocin 
A in the presence of 300/~g/ml of chloramphenicol, a concentration shown to 
be sufficient to stop protein synthesis. This indicated that the effect of streptocin 
A on RNA synthesis was independent of protein synthesis by the cells. 
The effect of streptocin A on RNA synthesis in strain PF 1643 was compared 
with that of a staphylococcal bacteriocin which  has previously been shown to 
bring about the degradation of RNA in a  susceptible Group A  streptococcus 
(12).  Both  bacteriocin preparations  used  in  this  experiment had  inhibitory 1176  GROUP  A  STREPTOCOCCAL  BACTERIOCIN 
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FIa. 4.~]The incorporation of [methyl-3H]thymidine  by Group A streptococcus  strain  PF 
1643 showing the effect of the addition (~)  of purified  streptocin A  (O---O) or 0.067 M 
phosphate buffer (O---O). 
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FI6. 5.  Effect on the uptake of [methyl3HJthymidine  by Group A streptococcus  strain PF 
I643 of the addition (~)  of purified  streptocin A  (O--O), the "inactivated" bacteriocin 
(V---V) or 0.067 M  phosphate buffer  (Q---O). 
titers of 16 when assayed on a  lawn culture of the indicator strain. In spite of 
this, the staphylococcal bacteriocin had a significantly more potent bactericidal 
effect against suspensions of the indicator cells, no viable CFU being detected 
after 3 h exposure. Moreover, as can be seen in Fig. 7 the rate of RNA degrada- TAGG~ DAJANI~ WANNAMAKER~ AND  GRAY  1177 
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Fro. 6. The  effect  of  the  addition  (~)  of  purified  streptocin A  (O--O)  or 0.067  M 
phosphate buffer (O--Q)  on the incorporation of [5-3H]uridine by  Group A streptococcus 
strain~PF 1643. 
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FI¢. 7.  Comparison of the effect of crude streptocin A, staphylococcin, or 0.067 M  phos- 
phate buffer on RNA synthesis by Group A streptococcus strain PF 1643, when exposed 30 
min (arrow 1) or 120 min (arrow 2) after the addition of [5-aH]uridine. The preparations added 
in each experiment were: curve A, 0.067 M phosphate buffer (30 min) and 0.067 M phosphate 
buffer  (120 rain); curve B, 0.067  M  phosphate  buffer  (1)  and  staphylocoecin  (2);  curve C, 
streptocin A  (l) and 0.067  M  phosphate  buffer  (2); curve D, streptocin A  (1) and staphylo- 
coccin (2). 1178  GROUP  A  STREPTOCOCCAL  BACTERIOCIN 
tion was  considerably greater after treatment of the indicator cells  with  the 
staphylococcal bacteriocin. 
Streptocin A was also found to prevent the incorporation of [14C]glucose into 
TCA-insoluble material  (Fig.  8).  Furthermore, total  [14C]glucose uptake  and 
also its incorporation into glycogen-like polymers were rapidly shut off after 
addition of the bacteriocin. 
DISCUSSION 
Our  previous  studies  of  bacteriocin  production  by  Group  A  streptococci 
failed to demonstrate the recovery of active material from broth cultures (5). 
It has been repeatedly demonstrated that the production of bacteriocins may be 
influenced considerably by the composition of the growth medium and condi- 
tions of incubation (1, 5, 13). Strains producing bacteriocin on solid media may 
show little or no activity in broth cultures (14-16). Moreover, it has been shown 
that some bacteriocinogenic organisms may also produce substances which are 
inhibitory to the homologous bacteriocin. Guterman and Luria (17)  described 
strains of E. coli excreting a neutralizing lipopolysaccharide material that de- 
creased the apparent yield of colicin. 
Other studies have indicated that an extracellular protease of Serralia  mar- 
cescens may reduce the amount of active bacteriocin recoverable from cultures of 
these organisms (18). Similarly, it seems that past failures to recover streptococ- 
cal bacteriocins from broth cultures may have been due to the inactivation of 
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FIG. 8. The ineorporation  of D-[14CJglucose  into acid-insoluble  material by Group A strep- 
tococcus strain PF 1643 and the effect of the addition ( ~, ) of crude streptocin A (O---©) or 
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the  bacteriocin  by  streptococcal  proteinase.  In  the  present  study  several 
different liquid media were tested as substrates for the production of streptocin 
A. Greatest yields were obtained from tryptic soy broth cultures. The recovery 
of the bacteriocin from Difco Todd-Hewitt broth, but not from Oxoid Todd- 
Hewitt broth, which had been utilized in our previous studies (4, 5), may be due 
to the presence of 2 % neopeptone in the former medium only. Neopeptone has 
been  shown  to  be  an  inhibitor of  streptococcal  proteinase  (11).  Additional 
indirect evidence supporting  the  possible  role of streptococcal proteinase in 
the inactivation of streptocin A was the apparent enhancement of bacteriocin 
production after mouse passage. Furthermore, our earlier studies (5) indicated 
that streptocin A production was greater in serum-containing and thus, pro- 
teinase-inactivating  (11)  media. 
From our present data, the optimal conditions for streptocin A production 
by strain FF-22  appear to be incubation in tryptic soy broth for 24-48  h  at 
35°C. The value of tryptic soy broth as a substrate for the production of bac- 
teriocins by staphylococci has previously been demonstrated in our own (19) 
and other (20) laboratories. An interesting, as yet unexplained observation, is 
the  failure  to  obtain  active bacteriocin  from freeze-thaw extracts  of FF-22 
cultures grown on tryptic soy agar (J. R. Tagg, unpublished data). 
Studies of the killing action of bacteriocins have indicated that the adsorption 
of a single particle may be sufficient to kill a susceptible cell. Luria (21) termed 
this "quantal" killing to distinguish it from the "molar" bactericidal activity 
of the classical antibiotics. Sensitive bacteria are thought to be killed by bac- 
teriocins in a  two-step process. The first stage involves the adsorption of the 
bacteriocin to cell-surface receptors. This is then followed by the transfer of a 
"lethal" message  to  specific  biochemical  targets  linked  to  the  cytoplasmic 
membrane, via the mediation of some amplification system (22, 23). It has been 
suggested that a chain reaction of bacteriocin-induced conformational changes 
in membrane subunits may serve as the specific transmission mechanism (24). 
Streptocin A  was shown to be bactericidal, but not lyric, for a  susceptible 
Group  A  streptococcus.  The  rate  of  this  lethal  effect was  temperature  de- 
pendent,  with relatively little killing occurring  at 4°C.  Similar temperature 
dependency of the bactericidal action has been noted in investigations of other 
bacteriocins  (6,  25)  and has been taken to indicate a  requirement for active 
cellular metabolism to effect the actual killing of the cells. In support of this, 
it was found in the present study that streptocin A was somewhat more lethal 
for cells in the exponential growth phase than those in stationary phase. Other 
investigators have found that sublethal concentrations of metabolic inhibitors 
such as dinitrophenol may serve to protect organisms from the killing action of 
bacteriocins  (25). 
Immunity of the bacteriocinogenic Group A  streptococcus to streptocin A 
was shown to be incomplete, since preparations having titers of greater than 16 
were  inhibitory to  the homologous producer  strain.  Although it is generally 1180  GROUP  A  STREPTOCOCCAL  BACTERIOCIN 
stated that bacteria are insensitive to their own bacteriocins, there have been 
numerous other demonstrations of breakdown of this immunity, in particular 
to bacteriocins produced  by gram-positive microorganisms  (26)  but  also  for 
some organisms producing colicins  (27)  or pyocins (28). 
Treatment of a  susceptible Group A  streptococcus with streptocin A  was 
shown to lead rapidly to the cessation of biosynthesis of the macromolecules, 
DNA, RNA, protein, and glycogen-like polymers. Furthermore, the quantity 
of  the  preaccurnulated TCA-precipitable  [3H]uridine  was markedly reduced, 
indicating the degradation of RNA.  This  effect was independent of protein 
synthesis in the treated cells.  Similar effects on macromolecule synthesis and 
RNA degradation have been shown to be associated with the lethal activity 
of two staphylococcal bacteriocins (12, 29). The phage type 71 staphylococcus 
bacteriocin  was  shown  to  cause  the  breakdown  of  both  newly formed  and 
previously formed RNA in susceptible organisms and it was speculated that this 
may occur via the activation of an endogenous nucleolytic system (12). 
The bactericidal activity of streptocin A in liquid media, including its effect 
on RNA degradation, was shown to be significantly less than that of prepara- 
tions of a staphylococcal bacteriocin having an identical inhibitory titer against 
the indicator strain in lawn culture assays. Several other investigators have 
similarly noted that the action of boticins (30),  pesticins (31),  or colicins (32) 
may also be substantially greater against susceptible organisms grown on agar 
medium than when grown in  broth.  In  any such studies it is important  to 
distinguish carefully between the determination of general inhibitory activity 
(including bacteriostatic effects) in lawn culture assays and the measurement 
of specific  bactericidal activity from viable counts of survivors after exposure 
to  the  bacteriocin. 
Streptocin A appears to have several properties in common with the phage 
type 71 staphylococcus bacteriocin, in addition to the aforementioned similarity 
in biochemical effects  on a susceptible bacterium. Production of both bacteriocins 
seems  excellent in  tryptic  soy broth  and  moreover,  both  are  noninducible, 
heat-stable,  extracellular products of the producer  strains and have broadly 
similar spectrums of activity against other organisms (5, 7). Significant differ- 
ences are  also  apparent  though. The staphylococcin appears  to be  stable in 
alkali and is nondialyzable (19). Furthermore, production of the staphylococcal 
bacteriocin is considerably greater in shaken tryptic soy broth cultures, while 
no streptocin A is recovered under these conditions. Interesting differences in 
the activity spectra are also apparent (5, 7). Streptocin A (but not the staphy- 
lococcin) has activity against Group B streptococci, but only the staphylococcin 
inhibits  strains  of  S.  aureus,  Bacillus  megaterium,  Listeria  monocytogenes, 
Corynebacterium diphtheriae, Diplococcus pneumoniae, and Group D  streptococci. 
Moreover, the immunity of the streptocin A producer strain to the homologous 
bacteriocin seems less complete than that of the staphylococcin producer to its 
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our preliminary experiments  (unpublished data)  have indicated a  failure of 
streptocin A to elicit the production of neutralizing antibodies, possibly due in 
part to its low molecular weight. In some of these properties streptocin A seems 
more closely to resemble the staphylococcal bacteriocin described  by Barrow 
(34)  which was slowly dialyzable, sensitive to alkaline pH but extremely heat 
resistant  when  acidic.  Lachowicz  and  Walczak  (35)  have  also  described  a 
staphylococcin having an active component of molecular weight 9,700,  similar 
in  size  to  streptocin A. All other  characterized bacteriocins have  been  sub- 
stantially larger,  making  streptocin  A  perhaps  the'  smallest  of  the  known 
bacteriocins. 
Our present studies are being directed towards the investigation of a possible 
role for streptocin A in the pathogenesis of rheumatic fever. It has been sug- 
gested (36) that the attachment to and damage of heart cells by streptocin A 
may lead  to  the  development of carditis in  some individuals infected with 
bacteriocinogenic Group A streptococci. More definitive studies of the toxicity 
of streptocin A for mammalian cells have necessarily been dependent upon the 
development of effective procedures for the production and purification of th  e 
bacteriocin such as those described in the present investigation. 
SUMMARY 
A bacteriocin, streptocin A, was isolated from the supernatant fluid of tryptic 
soy broth cultures of Group A streptococcus strain FF-22. Evidence was ob- 
tained which supports the view that the failure to recover active streptocin A 
after growth of the producer  strain in  certain fluid media is due  to  the  in- 
activation  of  the  bacteriocin  by  concomitantly  synthesized  streptococcal 
proteinase. 
The bacteriocin was purified 139-fold and the active product appeared to be 
of uniform size, having a molecular weight of approximately 8,000. 
Streptocin A was bactericidal, but not lyric, for a susceptible Group A strep- 
tococcus and the lethal effect was markedly temperature dependent. The bac- 
teriocin inhibited the synthesis of DNA, RNA, and protein, and also prevented 
the uptake and incorporation of glucose by the sensitive cells. 
Degradation of RNA occurred, but appeared to be less than that produced 
by a  staphylococcal bacteriocin. This effect may be due to differences in the 
killing potency of the two bacteriocins in preparations having similar inhibitory 
activity when measured by lawn culture assays. 
The authors acknowledge the excellent technical assistance of Zaiga Johnson and James 
Thoreson. 
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